KC
DCOY

Kepos Capital’s Decoy Therapeutics DCOY Stock Holding History

Kepos Capital’s Portfolio DCOY Stock Details DCOY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-15
Closed -$218K – 559
2022
Q1 		$218K Hold
15
– – 0.02% 316
2021
Q4 		$272K Hold
15
– – 0.02% 366
2021
Q3 		$559K Hold
15
– – 0.04% 347
2021
Q2 		$581K Hold
15
– – 0.04% 300
2021
Q1 		$811K Buy
15
+12
+400% +$688K 0.05% 292
2020
Q4 		$114K Hold
3
– – 0.01% 311
2020
Q3 		$105K Buy
+3
New +$119K 0.01% 242

Other funds holding DCOY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XSC
X-Square Capital Guaynabo, Puerto Rico $297M AUM 32.87% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return